Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (Breast Cancer Research and Treatment, (2017), 165, 2, (329-341), 10.1007/s10549-017-4304-7)

Javier Cortés, Hope S. Rugo, Ahmad Awada, Chris Twelves, Edith A. Perez, Seock–Ah –A Im, Patricia Gómez-Pardo, Lee S. Schwartzberg, Veronique Diéras, Denise A. Yardley, David A. Potter, Audrey Mailliez, Alvaro Moreno-Aspitia, Jin Seok Ahn, Carol Zhao, Ute Hoch, Mary Tagliaferri, Alison L. Hannah, Joyce O’Shaughnessy

Research output: Contribution to journalComment/debate

Abstract

The text in panel B of Fig. 1 (progression-free survival for patients with stable, treated brain metastases) was incorrectly labeled as mOS instead of mPFS. All other values and labels are correct. The corrected Figure 1 is given in this erratum.

Original languageEnglish (US)
Pages (from-to)327-328
Number of pages2
JournalBreast Cancer Research and Treatment
Volume166
Issue number1
DOIs
StatePublished - Nov 1 2017

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (Breast Cancer Research and Treatment, (2017), 165, 2, (329-341), 10.1007/s10549-017-4304-7)'. Together they form a unique fingerprint.

  • Cite this

    Cortés, J., Rugo, H. S., Awada, A., Twelves, C., Perez, E. A., Im, SA. A., Gómez-Pardo, P., Schwartzberg, L. S., Diéras, V., Yardley, D. A., Potter, D. A., Mailliez, A., Moreno-Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L., & O’Shaughnessy, J. (2017). Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (Breast Cancer Research and Treatment, (2017), 165, 2, (329-341), 10.1007/s10549-017-4304-7). Breast Cancer Research and Treatment, 166(1), 327-328. https://doi.org/10.1007/s10549-017-4482-3